Clinical Trial Update: Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]

View source ↗

Summary

Phase 4 trial update on Symbicort in airway-predominant COPD completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: National Jewish Health | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED